News

Wolfe Research Initiates Coverage of Oklo (OKLO) with Peer Perform Recommendation

OKLO

Fintel reports that on May 19, 2026, Wolfe Research initiated coverage of Oklo (NYSE:OKLO) with a Peer Perform recommendation. Analyst Price Forecast Suggests 69.27% Upside

Nasdaq Stocks - 2026-05-20 00:04:38

Alliance Global Partners Initiates Coverage of NeOnc Technologies Holdings (NTHI) with Buy Recommendation

NTHI

Fintel reports that on May 19, 2026, Alliance Global Partners initiated coverage of NeOnc Technologies Holdings (NasdaqGM:NTHI) with a Buy recommendation. Analyst Price Forecast Suggests 178.18% Upside

Nasdaq Stocks - 2026-05-20 00:04:35

Canaccord Genuity Upgrades Progyny (PGNY)

PGNY

Fintel reports that on May 19, 2026, Canaccord Genuity upgraded their outlook for Progyny (NasdaqGS:PGNY) from Hold to Buy. Analyst Price Forecast Suggests 16.83% Upside

Nasdaq Stocks - 2026-05-20 00:04:30

Asia markets poised for mixed open amid spike in Treasury yields, Iran tensions

Asia-Pacific markets were poised to open mixed on Wednesday as investors weighed elevated bond yields and renewed geopolitical tensions.

CNBC World - 2026-05-19 23:46:14
image

Adverts for DNA self-swab kits banned as misleading

The Advertising Standards Authority has ruled Enough's online posts contained unproven claims.

BBC Business - 2026-05-19 23:45:34
image

UK should set maximum working temperature rules, advisers say

Successive governments have failed to prepare the UK for extreme heat, the climate watchdog says.

BBC Business - 2026-05-19 23:40:12

Wolfe Research Initiates Coverage of Mirum Pharmaceuticals (MIRM) with Outperform Recommendation

MIRM

Fintel reports that on May 19, 2026, Wolfe Research initiated coverage of Mirum Pharmaceuticals (NasdaqGM:MIRM) with a Outperform recommendation. Analyst Price Forecast Suggests 56.11% Upside

Nasdaq Stocks - 2026-05-19 23:39:46

Citigroup Initiates Coverage of BridgeBio Pharma (BBIO) with Neutral Recommendation

BBIO

Fintel reports that on May 19, 2026, Citigroup initiated coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Neutral recommendation. Analyst Price Forecast Suggests 59.71% Upside

Nasdaq Stocks - 2026-05-19 23:31:38
image

Young drivers targeted by 'ghost brokers' selling fake car insurance online

The finance watchdog warns bogus brokers are selling fake car insurance through social media.

BBC Business - 2026-05-19 23:02:47

CAVA Group Q1 Earnings Call Highlights

CAVA

Shake Shack Stock Gets Shaken After Earnings MissCAVA Group (NYSE:CAVA) reported strong first-quarter 2026 results, with executives pointing to traffic gains, new restaurant performance and continued demand for Mediterranean cuisine as key drivers of growth. On the company’s ear

Nasdaq Earnings - 2026-05-19 23:02:42

Loading...

Market Overview

Hotlist

Economic Calendar